Cytomegalovirus in the neonate: Immune correlates of infection and protection

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Schleiss, Mark R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; DEFENSIN; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR; VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONGENITAL INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FETUS DISEASE; GAMMADELTA T CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NATURAL KILLER CELL; NEWBORN DISEASE; NONHUMAN; PHAGOCYTE; PLACENTA; PREGNANCY; PRIORITY JOURNAL; RECURRENT INFECTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; VERTICAL TRANSMISSION; IMMUNOLOGY; NEWBORN; REVIEW; CYTOMEGALOVIRUS INFECTIONS;

ADAPTIVE IMMUNITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN;

EID: 84884261212     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/501801     Document Type: Article

References (133)

1. Kenneson A., Cannon M. J., Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Reviews in Medical Virology 2007 17 4 253 276 2-s2.0-34447518917 10.1002/rmv.535
2. Wang C., Zhang X., Bialek S., Cannon M. J., Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clinical Infectious Diseases 2011 52 2 e11 e13 2-s2.0-79951826211 10.1093/cid/ciq085
3. Nyholm J. L., Schleiss M. R., Prevention of maternal cytomegalovirus infection: current status and future prospects. International Journal of Women's Health 2010 2 1 23 35 2-s2.0-77953401818
4. Oliver S. E., Cloud G. A., Sánchez P. J., Demmler G. J., Dankner W., Shelton M., Jacobs R. F., Vaudry W., Pass R. F., Soong S.-J., Whitley R. J., Kimberlin D. W., Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. Journal of Clinical Virology 2009 46 supplement 4 S22 S26 2-s2.0-71649099631 10.1016/j.jcv.2009.08.012
5. Whitley R. J., Congenital cytomegalovirus infection: epidemiology and treatment. Advances in Experimental Medicine and Biology 2004 549 155 160 2-s2.0-3242780934
6. Fowler K. B., Stagno S., Pass R. F., Maternal immunity and prevention of congenital cytomegalovirus infection. Journal of the American Medical Association 2003 289 8 1008 1011 2-s2.0-0037466917 10.1001/jama.289.8.1008
7. Yamamoto A. Y., Mussi-Pinhata M. M., Boppana S. B., Novak Z., Wagatsuma V. M., Oliveira P. D. F., Duarte G., Britt W. J., Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. American Journal of Obstetrics and Gynecology 2010 202 3 297.e1 297.e8 2-s2.0-77649184266 10.1016/j.ajog.2009.11. 018
8. Swanson E. C., Schleiss M. R., Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatric Clinics of North America 2013 60 2 335 349
9. Bristow B. N., O'Keefe K. A., Shafir S. C., Sorvillo F. J., Congenital cytomegalovirus mortality in the United States, 1990-2006. PLoS Neglected Tropical Diseases 2011 5 4 2-s2.0-79955801019 10.1371/journal.pntd.0001140 e1140
10. Fowler K. B., Stagno S., Pass R. F., Britt W. J., Boll T. J., Alford C. A., The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. The New England Journal of Medicine 1992 326 10 663 667 2-s2.0-0026513987
11. Lanari M., Capretti M. G., Lazzarotto T., Gabrielli L., Rizzollo S., Mostert M., Manzoni P., Neuroimaging in CMV congenital infected neonates: how and when. Early Human Development 2012 88 supplement 2 S3 S5
12. Schleiss M. R., Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infectious Disorders 2011 11 5 449 465 2-s2.0-80054100952
13. Hamprecht K., Witzel S., Maschmann J., Speer C. P., Jahn G., Transmission of cytomegalovirus infection through breast milk in term and preterm infants: the role of cell free milk whey and milk cells. Advances in Experimental Medicine and Biology 2000 478 231 239 2-s2.0-0034470643
14. Maschmann J., Hamprecht K., Dietz K., Jahn G., Speer C. P., Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clinical Infectious Diseases 2001 33 12 1998 2003 2-s2.0-0035893107 10.1086/324345
15. Bowden R. A., Slichter S. J., Sayers M., Weisdorf D., Cays M., Schoch G., Banaji M., Haake R., Welk K., Fisher L., McCullough J., Miller W., A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995 86 9 3598 3603 2-s2.0-0028820362
16. Dworsky M., Yow M., Stagno S., Pass R. F., Alford C., Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 1983 72 3 295 299 2-s2.0-0020551472
17. Schleiss M. R., Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern? Reviews in Medical Virology 2006 16 2 73 82 2-s2.0-33645232233 10.1002/rmv.484
18. Lanzieri T. M., Dollard S. C., Josephson C. D., Schmid D. S., Bialek S. R., Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics 2013 131 6 e1937 e1945
19. Gessler P., Bischoff G. A., Wiegand D., Essers B., Bossart W., Cytomegalovirus-associated necrotizing enterocolitis in a preterm twin after breastfeeding. Journal of Perinatology 2004 24 2 124 126 2-s2.0-1642527913 10.1038/sj.jp.7211042
20. Nijman J., de Vries L. S., Koopman-Esseboom C., Uiterwaal C. S. P. M., van Loon A. M., Verboon-Maciolek M. A., Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings. Archives of Disease in Childhood 2012 97 4 F259 F263 2-s2.0-84855798310 10.1136/archdischild-2011-300405
21. Capretti M. G., Lanari M., Lazzarotto T., Gabrielli L., Pignatelli S., Corvaglia L., Tridapalli E., Faldella G., Very low birth weight infants born to cytomegalovirus-seropositive mothers fed with their mother's milk: a prospective study. The Journal of Pediatrics 2009 154 6 842 848 2-s2.0-65549167431 10.1016/j.jpeds.2008.12.046
22. Bevot A., Hamprecht K., Krägeloh-Mann I., Brosch S., Goelz R., Vollmer B., Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk. Acta Paediatrica 2012 101 4 e167 e172 2-s2.0-84858073535 10.1111/j.1651-2227.2011.02538.x
23. Vollmer B., Seibold-Weiger K., Schmitz-Salue C., Hamprecht K., Goelz R., Krageloh-Mann I., Speer C. P., Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants. Pediatric Infectious Disease Journal 2004 23 4 322 327 2-s2.0-1942420314 10.1097/00006454-200404000-00009
24. Miller-Kittrell M., Sparer T. E., Feeling manipulated: cytomegalovirus immune manipulation. Virology Journal 2009 6, article 4 2-s2.0-60549097787 10.1186/1743-422X-6-4
25. Mussi-Pinhata M. M., Yamamoto A. Y., Brito R. M. M., De Isaac M. L., De Carvalho E Oliveira P. F., Boppana S., Britt W. J., Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clinical Infectious Diseases 2009 49 4 522 528 2-s2.0-67651113642 10.1086/600882
26. Boppana S. B., Fowler K. B., Britt W. J., Stagno S., Pass R. F., Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999 104 1 55 60 2-s2.0-0033017141 10.1542/peds.104.1.55
27. Sung H., Schleiss M. R., Update on the current status of cytomegalovirus vaccines. Expert Review of Vaccines 2010 9 11 1303 1314 2-s2.0-78649344229 10.1586/erv.10.125
28. Griffiths P. D., Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. The Lancet Infectious Diseases 2012 12 10 790 798
29. Johnson J., Anderson B., Pass R. F., Prevention of maternal and congenital cytomegalovirus infection. Clinical Obstetrics and Gynecology 2012 55 2 521 530 2-s2.0-84860287768 10.1097/GRF.0b013e3182510b7b
30. Schleiss M. R., Cytomegalovirus vaccine development. Current Topics in Microbiology and Immunology 2008 325 361 382 2-s2.0-48849085876 10.1007/978-3-540-77349-8-20
31. Wegmann T. G., Lin H., Guilbert L., Mosmann T. R., Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunology Today 1993 14 7 353 356 2-s2.0-0027207375
32. Sykes L., MacIntyre D. A., Yap X. J., Teoh T. G., Bennett P. R., The Th1:th2 dichotomy of pregnancy and preterm labour. Mediators of Inflammation 2012 2012 12 967629 10.1155/2012/967629
33. 2 Mediators of Inflammation 2012 2012 12 416739 10.1155/2012/416739
34. Jost S., Altfeld M., Control of human viral infections by natural killer cells. Annual Review of Immunology 2013 31 163 194
35. O'Leary J. G., Goodarzi M., Drayton D. L., von Andrian U. H., T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nature Immunology 2006 7 5 507 516 2-s2.0-33645989497 10.1038/ni1332
36. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S., Functions of natural killer cells. Nature Immunology 2008 9 5 503 510 2-s2.0-42449151214 10.1038/ni1582
37. Lash G. E., Robson S. C., Bulmer J. N., Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta 2010 31, supplement S87 S92 2-s2.0-76749133164 10.1016/j.placenta.2009.12.022
38. Trowsdale J., Betz A. G., Mother's little helpers: mechanisms of maternal-fetal tolerance. Nature Immunology 2006 7 3 241 246 2-s2.0-33645098806 10.1038/ni1317
39. Manaster I., Mandelboim O., The unique properties of uterine NK cells. American Journal of Reproductive Immunology 2010 63 6 434 444 2-s2.0-77953932635 10.1111/j.1600-0897.2009.00794.x
40. Manaster I., Mizrahi S., Goldman-Wohl D., Sela H. Y., Stern-Ginossar N., Lankry D., Gruda R., Hurwitz A., Bdolah Y., Haimov-Kochman R., Yagel S., Mandelboim O., Endometrial NK cells are special immature cells that await pregnancy. Journal of Immunology 2008 181 3 1869 1876 2-s2.0-49649094044
41. Whitelaw P. F., Croy B. A., Granulated lymphocytes of pregnancy. Placenta 1996 17 8 533 543 2-s2.0-0029830477
42. Strowig T., Brilot F., Münz C., Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. Journal of Immunology 2008 180 12 7785 7791 2-s2.0-46849090674
43. Muller W. J., Jones C. A., Koelle D. M., Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn. Current Immunology Reviews 2010 6 1 38 55 2-s2.0-77949707231 10.2174/157339510790231833
44. Siewiera J., El Costa H., Tabiasco J., Berrebi A., Cartron G., Bouteiller P., Jabrane-Ferrat N., Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathogens 2013 9 4 100325
45. Le Bouteiller P., Siewiera J., Casart Y., Aguerre-Girr M., El Costa H., Berrebi A., Tabiasco J., Jabrane-Ferrat N., The human decidual NK-cell response to virus infection: what can we learn from circulating NK lymphocytes? Journal of Reproductive Immunology 2011 88 2 170 175 2-s2.0-79952698448 10.1016/j.jri.2010.12.005
46. Biron C. A., Byron K. S., Sullivan J. L., Severe herpesvirus infections in an adolescent without natural killer cells. The New England Journal of Medicine 1989 320 26 1731 1735 2-s2.0-0024315206
47. Kohl S., Frazier J. J., Greenberg S. B., Pickering L. K., Loo L. S., Interferon induction of natural killer cytotoxicity in human neonates. The Journal of Pediatrics 1981 98 3 379 384 2-s2.0-0019464224
48. Noyola D. E., Fortuny C., Muntasell A., Noguera-Julian A., Munoz-Almagro C., Alarcon A., Juncosa T., Moraru M., Vilches C., Lopez-Botet M., Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. European Journal of Immunology 2012 42 12 3256 3266
49. McDonagh S., Maidji E., Chang H.-T., Pereira L., Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. Journal of Clinical Virology 2006 35 2 210 215 2-s2.0-30144440928 10.1016/j.jcv.2005.08.011
50. Quie P. G., White J. G., Holmes B., Good R. A., In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. The Journal of Clinical Investigation 1967 46 4 668 679 2-s2.0-0014078091
51. Rai N., Thakur N., Congenital CMV with LAD type 1 and NK cell deficiency. Journal of Pediatric Hematology/Oncology 2013 35 6 468 469
52. Salvador A., Najjar D., Hurt H., A preterm infant with a fatal congenital cytomegalovirus CMV infection. Journal of Perinatology 1990 10 2 228 229 2-s2.0-0025439546
53. Schwartz D. A., Khan R., Stoll B., Characterization of the fetal inflammatory response to cytomegalovirus placentitis. Archives of Pathology & Laboratory Medicine 1992 116 1 21 27 2-s2.0-0026526930
54. Liu Z., Tian Y., Wang B., Yan Z., Qian D., Ding S., Song X., Bai Z., Li L., Serum proteomics with SELDI-TOF-MS in congenital human cytomegalovirus hepatitis. Journal of Medical Virology 2007 79 10 1500 1505 2-s2.0-34548216804 10.1002/jmv.20927
55. Bácsi A., Aranyosi J., Beck Z., Ebbesen P., Andirkó I., Szabó J., Lampé L., Kiss J., Gergely L., Tóth F. D., Placental macrophage contact potentiates the complete replicative cycle of human cytomegalovirus in syncytiotrophoblast cells: role of interleukin-8 and transforming growth factor- β 1. Journal of Interferon and Cytokine Research 1999 19 10 1153 1160 2-s2.0-2442753374 10.1089/107999099313091
56. Weisblum Y., Panet A., Zichria Z.-R., Haimov-Kochman R., Goldman-Wohl D., Ariel I., Falk H., Natanson-Yaron S., Goldberg M. D., Gilad R., Lurain N. S., Greenfield C., Yagel S., Wolf D. G., Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. Journal of Virology 2011 85 24 13204 13213 2-s2.0-84855844357 10.1128/JVI.05749-11
57. Kumar H., Kawai T., Akira S., Toll-like receptors and innate immunity. Biochemical and Biophysical Research Communications 2009 388 4 621 625 2-s2.0-69949140723 10.1016/j.bbrc.2009.08.062
58. Kumar H., Kawai T., Akira S., Pathogen recognition by the innate immune system. International Reviews of Immunology 2011 30 1 16 34 2-s2.0-78751560494 10.3109/08830185.2010.529976
59. Kijpittayarit S., Eid A. J., Brown R. A., Paya C. V., Razonable R. R., Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clinical Infectious Diseases 2007 44 10 1315 1320 2-s2.0-34248190825 10.1086/514339
60. Kang S. H., Abdel-Massih R. C., Brown R. A., Dierkhising R. A., Kremers W. K., Razonable R. R., Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation. The Journal of Infectious Diseases 2012 205 4 639 646 2-s2.0-84856264424 10.1093/infdis/jir819
61. Chaudhuri S., Lowen B., Chan G., Davey A., Riddell M., Guilbert L. J., Human cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNFalpha mRNA and apoptosis. Placenta 2009 30 11 994 1001 2-s2.0-70350767285 10.1016/j.placenta.2009.09.001
62. Chan G., Guilbert L. J., Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor- α dependent manner. Journal of Pathology 2006 210 1 111 120 2-s2.0-33747877119 10.1002/path.2025
63. Boehme K. W., Guerrero M., Compton T., Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. Journal of Immunology 2006 177 10 7094 7102 2-s2.0-33750827767
64. Juckem L. K., Boehme K. W., Feire A. L., Compton T., Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. Journal of Immunology 2008 180 7 4965 4977 2-s2.0-44449122887
65. Casrouge A., Zhang S.-Y., Eidenschenk C., Jouanguy E., Puel A., Yang K., Alcais A., Picard C., Mahfoufi N., Nicolas N., Lorenzo L., Plancoulaine S., Sénéchal B., Geissmann F., Tabeta K., Hoebe K., Du X., Miller R. L., Héron B., Mignot C., Billette De Villemeur T., Lebon P., Dulac O., Rozenberg F., Beutler B., Tardieu M., Abel L., Casanova J.-L., Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006 314 5797 308 312 2-s2.0-33750016788 10.1126/science.1128346
66. Zhang S.-Y., Jouanguy E., Ugolini S., Smahi A., Elain G., Romero P., Segal D., Sancho-Shimizu V., Lorenzo L., Puel A., Picard C., Chapgier A., Plancoulaine S., Titeux M., Cognet C., Von Bernuth H., Ku C.-L., Casrouge A., Zhang X.-X., Barreiro L., Leonard J., Hamilton C., Lebon P., Héron B., Vallée L., Quintana-Murci L., Hovnanian A., Rozenberg F., Vivier E., Geissmann F., Tardieu M., Abel L., Casanova J.-L., TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007 317 5844 1522 1527 2-s2.0-34548699323 10.1126/science.1139522
67. Nahum A., Dadi H., Bates A., Roifman C. M., The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity. Autoimmunity Reviews 2012 11 5 341 347 2-s2.0-84857506024 10.1016/j.autrev.2011.10.007
68. Mezger M., Bonin M., Kessler T., Gebhardt F., Einsele H., Loeffler J., Toll-like receptor 3 has no critical role during early immune response of human monocyte-derived dendritic cells after infection with the human cytomegalovirus strain TB40E. Viral Immunology 2009 22 6 343 351 2-s2.0-71449095849 10.1089/vim.2009.0011
69. Arav-Boger R., Wojcik G. L., Duggal P., Ingersoll R. G., Beaty T., Pass R. F., Yolken R. H., Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine. BMC Research Notes 2012 5, article 140 2-s2.0-84857929332 10.1186/1756-0500-5-140
70. Roth I., Corry D. B., Locksley R. M., Abrams J. S., Litton M. J., Fisher S. J., Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. The Journal of Experimental Medicine 1996 184 2 539 548 2-s2.0-0029788698
71. Scott G. M., Chow S. S. W., Craig M. E., Pang C. N. I., Hall B., Wilkins M. R., Jones C. A., Lloyd A. R., Rawlinson W. D., Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. The Journal of Infectious Diseases 2012 205 8 1305 1310 2-s2.0-84859054099 10.1093/infdis/jis186
72. Arsenescu R., Arsenescu V., de Villiers W. J. S., TNF- α and the development of the neonatal immune system: implications for inhibitor use in pregnancy. The American Journal of Gastroenterology 2011 106 4 559 562 2-s2.0-79953795330 10.1038/ajg.2011.5
73. Gisbert J. P., Chaparro M., Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease. The American Journal of Gastroenterology 2013 10.1038/ajg.2013.171
74. Velilla P. A., Rugeles M. T., Chougnet C. A., Defective antigen-presenting cell function in human neonates. Clinical Immunology 2006 121 3 251 259 2-s2.0-33751115728 10.1016/j.clim.2006.08.010
75. Drohan L., Harding J. J., Holm B., Cordoba-Tongson E., Dekker C. L., Holmes T., Maecker H., Mellins E. D., Selective developmental defects of cord blood antigen-presenting cell subsets. Human Immunology 2004 65 11 1356 1369 2-s2.0-8844225618 10.1016/j.humimm.2004.09.011
76. Renneson J., Dutta B., Goriely S., Danis B., Lecomte S., Laes J.-F., Tabi Z., Goldman M., Marchant A., IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection. European Journal of Immunology 2009 39 10 2789 2799 2-s2.0-70350536363 10.1002/eji.200939414
77. Hassan J., Dooley S., Hall W., Immunological response to cytomegalovirus in congenitally infected neonates. Clinical and Experimental Immunology 2007 147 3 465 471 2-s2.0-33846818685 10.1111/j.1365-2249.2007.03302.x
78. Hamilton S. T., Scott G., Naing Z., Iwasenko J., Hall B., Graf N., Arbuckle S., Craig M. E., Rawlinson W. D., Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PloS One 2012 7 12 e52899
79. Griffiths P., Plotkin S., Mocarski E., Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine 2013 31 supplement 2 B197 B203
80. Visentin S., Manara R., Milanese L., Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clinical Infectious Diseases 2012 55 4 497 503
81. Polilli E., Parruti G., D'Arcangelo F., Preliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection. Clinical and Vaccine Immunology 2012 19 12 1991 1993
82. Rola Pleszczynski M., Frenkel L. D., Fuccillo D. A., Specific impairment of cell mediated immunity in mothers of infants with congenital infection due to cytomegalovirus. The Journal of Infectious Diseases 1977 135 3 386 391 2-s2.0-0017616467
83. Starr S. E., Tolpin M. D., Friedman H. M., Paucker K., Plotkin S. A., Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. The Journal of Infectious Diseases 1979 140 4 500 505 2-s2.0-0018577552
84. Fujikawa T., Numazaki K., Asanuma H., Kudo R., Tsutsumi H., Frequency of human cytomegalovirus-specific T cells during pregnancy determined by intracellular cytokine staining. Journal of Medical Virology 2003 71 4 527 531 2-s2.0-0142182282 10.1002/jmv.10556
85. Lilleri D., Fornara C., Furione M., Zavattoni M., Revello M. G., Gerna G., Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. The Journal of Infectious Diseases 2007 195 7 1062 1070 2-s2.0-33947418134 10.1086/512245
86. Revello M. G., Lilleri D., Zavattoni M., Furione M., Genini E., Comolli G., Gerna G., Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers. The Journal of Infectious Diseases 2006 193 2 269 276 2-s2.0-30944438250 10.1086/498872
87. Stern H., Hannington G., Booth J., Moncrieff D., An early marker of fetal infection after primary cytomegalovirus infection in pregnancy. British Medical Journal 1986 292 6522 718 720 2-s2.0-0022654429
88. Fernando S., Pearce J. M., Booth J. C., Lymphocyte responses and virus excretion as risk factors for intrauterine infection with cytomegalovirus. Journal of Medical Virology 1993 41 2 108 113 2-s2.0-0027363683 10.1002/jmv.1890410205
89. Fornara C., Lilleri D., Revello M. G., Furione M., Zavattoni M., Lenta E., Gerna G., Kinetics of effector functions and phenotype of virus-specific and γ δ T lymphocytes in primary human cytomegalovirus infection during pregnancy. Journal of Clinical Immunology 2011 31 6 1054 1064 2-s2.0-84857053641 10.1007/s10875-011-9577-8
90. Lilleri D., Fornara C., Revello M. G., Gerna G., Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection. The Journal of Infectious Diseases 2008 198 4 536 543 2-s2.0-48749127711 10.1086/590118
91. Tu W., Chen S., Sharp M., Dekker C., Manganello A. M., Tongson E. C., Maecker H. T., Holmes T. H., Wang Z., Kemble G., Adler S., Arvin A., Lewis D. B., Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. Journal of Immunology 2004 172 5 3260 3267 2-s2.0-10744232580
92. Fujikawa T., Numazaki K., Asanuma H., Tsutsumi H., Human cytomegalovirus infection during pregnancy and detection of specific T cells by intracellular cytokine staining. International Journal of Infectious Diseases 2003 7 3 215 221 2-s2.0-0142215434 10.1016/S1201-9712(03)90055-5
93. Hayashi N., Kimura H., Morishima T., Tanaka N., Tsurumi T., Kuzushima K., Flow cytometric analysis of cytomegalovirus-specific cell-mediated immunity in the congenital infection. Journal of Medical Virology 2003 71 2 251 258 2-s2.0-0041358725 10.1002/jmv.10477
94. Lidehall A. K., Engman M. L., Sund F., Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children. Scandinavian Journal of Immunology 2013 77 2 135 143
95. Fornara O., Odeberg J., Khan Z., Stragliotto G., Peredo I., Butler L., Söderberg-Nauclér C., Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation. Immunobiology 2013 218 8 1034 1040
96. Teles A., Zenclussen A. C., Schumacher A., Regulatory T cells are baby's best friends. American Journal of Reproductive Immunology 2013 69 4 331 339
97. Rowe J. H., Ertelt J. M., Xin L., Way S. S., Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 2012 490 7418 102 106
98. Rouse B. T., Sarangi P. P., Suvas S., Regulatory T cells in virus infections. Immunological Reviews 2006 212 272 286 2-s2.0-33746383248 10.1111/j.0105-2896.2006.00412.x
99. Belkaid Y., Regulatory T cells and infection: a dangerous necessity. Nature Reviews Immunology 2007 7 11 875 888 2-s2.0-34748873441 10.1038/nri2189
100. Egli A., Silva M. Jr., O'Shea D., Wilson L. E., Baluch A., Lisboa L. F., Hidalgo L. G., Kumar D., Humar A., An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients. PloS One 2012 7 11 e43937
101. Aandahl E. M., Michaëlsson J., Moretto W. J., Hecht F. M., Nixon D. F., Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. Journal of Virology 2004 78 5 2454 2459 2-s2.0-10744227590 10.1128/JVI.78.5.2454-2459.2004
102. Velaga S., Ukena S. N., Hopting M., Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation. Immunological Investigations 2013 42 1 18 35
103. La Rosa C., Diamond D. J., The immune response to human CMV. Future Virology 2012 7 3 279 293 2-s2.0-84858377588 10.2217/fvl.12.8
104. Wills M. R., Carmichael A. J., Mynard K., Jin X., Weekes M. P., Plachter B., Sissons J. G. P., The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. Journal of Virology 1996 70 11 7569 7579 2-s2.0-0029847916
105. Elkington R., Walker S., Crough T., Menzies M., Tellam J., Bharadwaj M., Khanna R., Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. Journal of Virology 2003 77 9 5226 5240 2-s2.0-0345373932 10.1128/JVI.77.9.5226-5240. 2003
106. Sylwester A. W., Mitchell B. L., Edgar J. B., Taormina C., Pelte C., Ruchti F., Sleath P. R., Grabstein K. H., Hosken N. A., Kern F., Nelson J. A., Picker L. J., Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. The Journal of Experimental Medicine 2005 202 5 673 685 2-s2.0-24344489044 10.1084/jem.20050882
107. Hassan J., Connell J., Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on. Clinical and Experimental Immunology 2007 149 2 205 210 2-s2.0-34447308745 10.1111/j.1365-2249.2007.03454.x
108. Gibson L., Donley S., Trzmielina S., Somasundaran M., Fisher D., Revello M. G., Luzuriaga K., Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants. The Journal of Infectious Diseases 2007 195 12 1789 1798 2-s2.0-34249907536 10.1086/518042
109. Pédron B., Guérin V., Jacquemard F., Munier A., Daffos F., Thulliez P., Aujard Y., Luton D., Sterkers G., Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. The Journal of Infectious Diseases 2007 196 7 1033 1043 2-s2.0-35348854365 10.1086/521196
110. Ould M. A. E., Luton D., Yadini M., Pedron B., Aujard Y., Jacqz-Aigrain E., Jacquemard F., Sterkers G., Cellular immune response of fetuses to cytomegalovirus. Pediatric Research 2004 55 2 280 286 2-s2.0-1642514956 10.1203/01.PDR.0000104150.85437.FE
111. Marchant A., Appay V., Van Der Sande M., Dulphy N., Liesnard C., Kidd M., Kaye S., Ojuola O., Gillespie G. M. A., Vargas Cuero A. L., Cerundolo V., Callan M., McAdam K. P. W. J., Rowland-Jones S. L., Donner C., McMichael A. J., Whittle H., Mature CD8+ T lymphocyte response to viral infection during fetal life. The Journal of Clinical Investigation 2003 111 11 1747 1755 2-s2.0-0038481177
112. Marchant A., Goldman M., T cell-mediated immune responses in human newborns: ready to learn? Clinical and Experimental Immunology 2005 141 1 10 18 2-s2.0-21344451855 10.1111/j.1365-2249.2005.02799.x
113. Holt P. G., Functionally mature virus-specific CD8+ T memory cells in congenitally infected newborns: proof of principle for neonatal vaccination? The Journal of Clinical Investigation 2003 111 11 1645 1647 2-s2.0-0038481193
114. Born W. K., Jin N., Aydintug M. K., Wands J. M., French J. D., Roark C. L., O'Brien R. L., γ δ T lymphocytes-selectable cells within the innate system? Journal of Clinical Immunology 2007 27 2 133 144 2-s2.0-33847360982 10.1007/s10875-007-9077-z
115. Vermijlen D., Brouwer M., Donner C., Liesnard C., Tackoen M., Van Rysselberge M., Twité N., Goldman M., Marchant A., Willems F., Human cytomegalovirus elicits fetal γ δ T cell responses in utero. The Journal of Experimental Medicine 2010 207 4 807 821 2-s2.0-77951058003 10.1084/jem.20090348
116. Pass R. F., Zhang C. H., Evans A., Simpson T., Andrews W., Huang M.-L., Corey L., Hill J., Davis E., Flanigan C., Cloud G., Vaccine prevention of maternal cytomegalovirus infection. The New England Journal of Medicine 2009 360 12 1191 1199 2-s2.0-62749097289 10.1056/NEJMoa0804749
117. Griffiths P. D., Stanton A., McCarrell E., Smith C., Osman M., Harber M., Davenport A., Jones G., Wheeler D. C., OBeirne J., Thorburn D., Patch D., Atkinson C. E., Pichon S., Sweny P., Lanzman M., Woodford E., Rothwell E., Old N., Kinyanjui R., Haque T., Atabani S., Luck S., Prideaux S., Milne R. S., Emery V. C., Burroughs A. K., Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. The Lancet 2011 377 9773 1256 1263 2-s2.0-79953743926 10.1016/S0140-6736(11)60136-0
118. Sabbaj S., Pass R. F., Goepfert P. A., Pichon S., Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. The Journal of Infectious Diseases 2011 203 11 1534 1541 2-s2.0-79956213270 10.1093/infdis/jir138
119. Schleiss M. R., Could therapeutic vaccination of cytomegalovirus- seropositive persons prevent reinfection and congenital virus transmission? The Journal of Infectious Diseases 2011 203 11 1513 1516 2-s2.0-79956210577 10.1093/infdis/jir144
120. Chakravarty E. F., Murray E. R., Kelman A., Farmer P., Pregnancy outcomes after maternal exposure to rituximab. Blood 2011 117 5 1499 1506 2-s2.0-79551617381 10.1182/blood-2010-07-295444
121. Le Clech L., Ianotto J. C., Quintin-Roue I., Tempescul A., Severe CMV complication following maintenance therapy with rituximab. BMJ Case Reports 2013 10.1136/bcr-2012-006672
122. Ahlfors K., Ivarsson S.-A., Harris S., Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scandinavian Journal of Infectious Diseases 1999 31 5 443 457 2-s2.0-0032749448 10.1080/ 00365549950163969
123. Ross S. A., Arora N., Novak Z., Fowler K. B., Britt W. J., Boppana S. B., Cytomegalovirus reinfections in healthy seroimmune women. The Journal of Infectious Diseases 2010 201 3 386 389 2-s2.0-75649126559 10.1086/649903
124. Nigro G., Adler S. P., La Torre R., Best A. M., Congenital Cytomegalovirus Collaborating Group, Passive immunization during pregnancy for congenital cytomegalovirus infection. The New England Journal of Medicine 2005 353 13 1350 1362 2-s2.0-25444434851 10.1056/NEJMoa043337
125. McCarthy F. P., Giles M. L., Rowlands S., Purcell K. J., Jones C. A., Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. Cochrane Database of Systematic Reviews 2011 3 CD008371 2-s2.0-79953267829
126. Nigro G., La Torre R., Pentimalli H., Taverna P., Lituania M., De Tejada B. M., Adler S. P., Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenatal Diagnosis 2008 28 6 512 517 2-s2.0-46749090966 10.1002/pd.2013
127. Nigro G., Adler S. P., Parruti G., Anceschi M. M., Coclite E., Pezone I., Di Renzo G. C., Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy-a case-control study of the outcome in children. The Journal of Infectious Diseases 2012 205 2 215 227 2-s2.0-84555187476 10.1093/infdis/jir718
128. Fouts A. E., Chan P., Stephan J. P., Vandlen R., Feierbach B., Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin. Journal of Virology 2012 86 13 7444 7447
129. Buxmann H., Stackelberg O. M., Schlosser R. L., Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. Journal of Perinatal Medicine 2012 40 4 439 446
130. La Torre R., Nigro G., Mazzocco M., Best A. M., Adler S. P., Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clinical Infectious Diseases 2006 43 8 994 1000 2-s2.0-33750319298 10.1086/507634
131. Maidji E., Nigro G., Tabata T., McDonagh S., Nozawa N., Shiboski S., Muci S., Anceschi M. M., Aziz N., Adler S. P., Pereira L., Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. American Journal of Pathology 2010 177 3 1298 1310 2-s2.0-77956539713 10.2353/ajpath.2010.091210
132. Maidji E., McDonagh S., Genbacev O., Tabata T., Pereira L., Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. American Journal of Pathology 2006 168 4 1210 1226 2-s2.0-33645456384 10.2353/ajpath.2006.050482
133. Neto E. C., Rubin R., Schulte J., Giugliani R., Newborn screening for congenital infectious diseases. Emerging Infectious Diseases 2004 10 6 1069 1073 2-s2.0-3543151282